Edison, New Jersey — A newly emerging strain of the flu is raising alarm across the United States, earning the nickname “super flu.” The mutation, a subclade of the influenza A(H3N2) virus known as K, is contributing to a spike in infections and fatalities, including the season’s first reported pediatric flu death in New Jersey.

The Centers for Disease Control and Prevention (CDC) reports at least 180,000 hospitalizations and approximately 7,400 deaths from influenza this season. Of these cases, a significant majority have been linked to the A(H3N2) strain, specifically subclade K, which accounts for an alarming 91.5% of the tested samples.

Health experts are concerned about the strain’s rapid spread and unique characteristics. Flu viruses continuously evolve, complicating efforts to predict which strains will circulate in any given season. The CDC’s vaccine formulation, decided in February, did not anticipate subclade K’s emergence in August, leading to a potential mismatch that could affect vaccine effectiveness.

Dr. Adeel Butt, an infectious disease specialist at JFK University Medical Center, noted the challenges posed by this evolving virus. “This strain developed after the vaccine was formulated, which means the vaccine may not provide full protection against this year’s variant,” he explained. Despite this, preliminary evidence suggests the vaccine still retains a degree of effectiveness in preventing severe illness, particularly in children and younger populations.

Despite the subclade K’s emergence, current epidemiological data doesn’t indicate a significant increase in disease severity. The World Health Organization acknowledges subclade K as a notable evolution but insists it isn’t leading to a more dangerous outbreak at this time.

Early data from the UK Health Security Agency suggests that the 2025-2026 flu vaccine is about 70% to 75% effective in preventing hospital visits among children aged 2 to 17, and 30% to 40% effective in adults. Dr. Daniel Ruderfer, a pediatric infectious diseases expert at K. Hovnanian Children’s Hospital, corroborates these findings. He observed better overall outcomes among vaccinated children, emphasizing that most severely ill patients in hospitals are unvaccinated.

Vaccination rates, however, are on the decline, raising concerns among health professionals. According to the CDC, flu vaccination coverage among children has dropped to 49.2% for the 2024-2025 season, a significant decline from previous years. The last time figures were this low was in 2011, highlighting a worrying trend in public health efforts.

Even though the flu vaccine isn’t foolproof, health officials stress its importance in mitigating severe illness and death associated with the virus. Typically, flu vaccines reduce the incidence of severe illness by 40% to 60%. “Vaccination is still the best method to protect against influenza and its complications,” Dr. Butt stated, dispelling the myth that flu shots can cause the illness.

It typically takes about two weeks for the body to build immunity following vaccination, leaving the possibility for some individuals to contract influenza if exposed before sufficient antibodies develop. Public health experts emphasize that while the vaccine may not completely prevent infection, it significantly lowers the risk of severe outcomes.

This flu season is far from over, making it essential for individuals, especially children, to get vaccinated. Flu season typically spans from October through May, and currently, nearly 15 states are experiencing heightened flu activity, expected to continue in the coming weeks. Vaccines are available for anyone aged 6 months and older through various healthcare providers, pharmacies, and community clinics.

For guidance on finding flu vaccination locations, individuals are encouraged to visit the CDC website. As the flu continues to spread, the importance of vaccination cannot be overstated, especially amidst concerns about evolving strains.